6,633
Views
172
CrossRef citations to date
0
Altmetric
Research Article

Chalcones isolated from Angelica keiskei inhibit cysteine proteases of SARS-CoV

, , , , , , , , & show all
Pages 23-30 | Received 03 Sep 2014, Accepted 16 Dec 2014, Published online: 16 Feb 2015
 

Abstract

Two viral proteases of severe acute respiratory syndrome coronavirus (SARS-CoV), a chymotrypsin-like protease (3CLpro) and a papain-like protease (PLpro) are attractive targets for the development of anti-SARS drugs. In this study, nine alkylated chalcones (19) and four coumarins (1013) were isolated from Angelica keiskei, and the inhibitory activities of these constituents against SARS-CoV proteases (3CLpro and PLpro) were determined (cell-free/based). Of the isolated alkylated chalcones, chalcone 6, containing the perhydroxyl group, exhibited the most potent 3CLpro and PLpro inhibitory activity with IC50 values of 11.4 and 1.2 µM. Our detailed protein-inhibitor mechanistic analysis of these species indicated that the chalcones exhibited competitive inhibition characteristics to the SARS-CoV 3CLpro, whereas noncompetitive inhibition was observed with the SARS-CoV PLpro.

Declaration of interest

This research was supported by KRIBB Research Initiative Program and Fishery Commercialization Technology Development Program through KIMST (Korea Institute of Marine Science & Technology promotion) funded by Ministry of Oceans and Fisheries (MOF), Republic of Korea.

Supplementary material available online

Supplementary information

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.